<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang xml:lang>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Your Digest for Tuesday, Jan 23, 2024 10:59 AM</title>
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    span.underline{text-decoration: underline;}
    div.column{display: inline-block; vertical-align: top; width: 50%;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
  </style>
  <style type="text/css">
:root,
::backdrop {

--sans-font: -apple-system, BlinkMacSystemFont, "Avenir Next", Avenir,
"Nimbus Sans L", Roboto, "Noto Sans", "Segoe UI", Arial, Helvetica,
"Helvetica Neue", sans-serif;
--mono-font: Consolas, Menlo, Monaco, "Andale Mono", "Ubuntu Mono", monospace;
--standard-border-radius: 5px;

--bg: #fff;
--accent-bg: #f5f7ff;
--text: #212121;
--text-light: #585858;
--border: #898EA4;
--accent: #0d47a1;
--code: #d81b60;
--preformatted: #444;
--marked: #ffdd33;
--disabled: #efefef;
}

@media (prefers-color-scheme: dark) {
:root,
::backdrop {
color-scheme: dark;
--bg: #212121;
--accent-bg: #2b2b2b;
--text: #dcdcdc;
--text-light: #ababab;
--accent: #ffb300;
--code: #f06292;
--preformatted: #ccc;
--disabled: #111;
}

img,
video {
opacity: 0.8;
}
}

*, *::before, *::after {
box-sizing: border-box;
}

textarea,
select,
input,
progress {
appearance: none;
-webkit-appearance: none;
-moz-appearance: none;
}
html {

font-family: var(--sans-font);
scroll-behavior: smooth;
}

body {
color: var(--text);
background-color: var(--bg);
font-size: 1.15rem;
line-height: 1.5;
display: grid;
grid-template-columns: 1fr min(45rem, 90%) 1fr;
margin: 0;
}
body > * {
grid-column: 2;
}

body > header {
background-color: var(--accent-bg);
border-bottom: 1px solid var(--border);
text-align: center;
padding: 0 0.5rem 2rem 0.5rem;
grid-column: 1 / -1;
}
body > header h1 {
max-width: 1200px;
margin: 1rem auto;
}
body > header p {
max-width: 40rem;
margin: 1rem auto;
}

main {
padding-top: 1.5rem;
}
body > footer {
margin-top: 4rem;
padding: 2rem 1rem 1.5rem 1rem;
color: var(--text-light);
font-size: 0.9rem;
text-align: center;
border-top: 1px solid var(--border);
}

h1 {
font-size: 3rem;
}
h2 {
font-size: 2.6rem;
margin-top: 3rem;
}
h3 {
font-size: 2rem;
margin-top: 3rem;
}
h4 {
font-size: 1.44rem;
}
h5 {
font-size: 1.15rem;
}
h6 {
font-size: 0.96rem;
}

p, h1, h2, h3, h4, h5, h6 {
overflow-wrap: break-word;
}

h1,
h2,
h3 {
line-height: 1.1;
}

@media only screen and (max-width: 720px) {
h1 {
font-size: 2.5rem;
}
h2 {
font-size: 2.1rem;
}
h3 {
font-size: 1.75rem;
}
h4 {
font-size: 1.25rem;
}
}

a,
a:visited {
color: var(--accent);
}
a:hover {
text-decoration: none;
}
button,
.button,
a.button, 
input[type="submit"],
input[type="reset"],
input[type="button"],
label[type="button"] {
border: none;
border-radius: var(--standard-border-radius);
background-color: var(--accent);
font-size: 1rem;
color: var(--bg);
padding: 0.7rem 0.9rem;
margin: 0.5rem 0;
text-decoration: none;
font-family: inherit;
line-height: normal;
}
.button[aria-disabled="true"], input:disabled,
textarea:disabled,
select:disabled,
button[disabled] {
cursor: not-allowed;
background-color: var(--disabled);
color: var(--text-light)
}
input[type="range"] {
padding: 0;
}

abbr[title] {
cursor: help;
text-decoration-line: underline;
text-decoration-style: dotted;
}
button:enabled:hover,
.button:not([aria-disabled="true"]):hover,
input[type="submit"]:enabled:hover,
input[type="reset"]:enabled:hover,
input[type="button"]:enabled:hover,
label[type="button"]:hover {
filter: brightness(1.4);
cursor: pointer;
}
.button:focus-visible,
button:focus-visible:where(:enabled),
input:enabled:focus-visible:where(
[type="submit"],
[type="reset"],
[type="button"]
) {
outline: 2px solid var(--accent);
outline-offset: 1px;
}

header > nav {
font-size: 1rem;
line-height: 2;
padding: 1rem 0 0 0;
}

header > nav ul,
header > nav ol {
align-content: space-around;
align-items: center;
display: flex;
flex-direction: row;
flex-wrap: wrap;
justify-content: center;
list-style-type: none;
margin: 0;
padding: 0;
}

header > nav ul li,
header > nav ol li {
display: inline-block;
}
header > nav a,
header > nav a:visited {
margin: 0 0.5rem 1rem 0.5rem;
border: 1px solid var(--border);
border-radius: var(--standard-border-radius);
color: var(--text);
display: inline-block;
padding: 0.1rem 1rem;
text-decoration: none;
}
header > nav a:hover,
header > nav a.current,
header > nav a[aria-current="page"] {
border-color: var(--accent);
color: var(--accent);
cursor: pointer;
}

@media only screen and (max-width: 720px) {
header > nav a {
border: none;
padding: 0;
text-decoration: underline;
line-height: 1;
}
}

aside, details, pre, progress {
background-color: var(--accent-bg);
border: 1px solid var(--border);
border-radius: var(--standard-border-radius);
margin-bottom: 1rem;
}
aside {
font-size: 1rem;
width: 30%;
padding: 0 15px;
margin-inline-start: 15px;
float: right;
}
*[dir="rtl"] aside {
float: left;
}

@media only screen and (max-width: 720px) {
aside {
width: 100%;
float: none;
margin-inline-start: 0;
}
}
article, fieldset, dialog {
border: 1px solid var(--border);
padding: 1rem;
border-radius: var(--standard-border-radius);
margin-bottom: 1rem;
}
article h2:first-child,
section h2:first-child {
margin-top: 1rem;
}
section {
border-top: 1px solid var(--border);
border-bottom: 1px solid var(--border);
padding: 2rem 1rem;
margin: 3rem 0;
}

section + section,
section:first-child {
border-top: 0;
padding-top: 0;
}
section:last-child {
border-bottom: 0;
padding-bottom: 0;
}
details {
padding: 0.7rem 1rem;
}
summary {
cursor: pointer;
font-weight: bold;
padding: 0.7rem 1rem;
margin: -0.7rem -1rem;
word-break: break-all;
}
details[open] > summary + * {
margin-top: 0;
}
details[open] > summary {
margin-bottom: 0.5rem;
}
details[open] > :last-child {
margin-bottom: 0;
}

table {
border-collapse: collapse;
margin: 1.5rem 0;
}
td,
th {
border: 1px solid var(--border);
text-align: start;
padding: 0.5rem;
}
th {
background-color: var(--accent-bg);
font-weight: bold;
}
tr:nth-child(even) {

background-color: var(--accent-bg);
}
table caption {
font-weight: bold;
margin-bottom: 0.5rem;
}

textarea,
select,
input {
font-size: inherit;
font-family: inherit;
padding: 0.5rem;
margin-bottom: 0.5rem;
color: var(--text);
background-color: var(--bg);
border: 1px solid var(--border);
border-radius: var(--standard-border-radius);
box-shadow: none;
max-width: 100%;
display: inline-block;
}
label {
display: block;
}
textarea:not([cols]) {
width: 100%;
}

select:not([multiple]) {
background-image: linear-gradient(45deg, transparent 49%, var(--text) 51%),
linear-gradient(135deg, var(--text) 51%, transparent 49%);
background-position: calc(100% - 15px), calc(100% - 10px);
background-size: 5px 5px, 5px 5px;
background-repeat: no-repeat;
padding-inline-end: 25px;
}
*[dir="rtl"] select:not([multiple]) {
background-position: 10px, 15px;
}

input[type="checkbox"],
input[type="radio"] {
vertical-align: middle;
position: relative;
width: min-content;
}
input[type="checkbox"] + label,
input[type="radio"] + label {
display: inline-block;
}
input[type="radio"] {
border-radius: 100%;
}
input[type="checkbox"]:checked,
input[type="radio"]:checked {
background-color: var(--accent);
}
input[type="checkbox"]:checked::after {

content: " ";
width: 0.18em;
height: 0.32em;
border-radius: 0;
position: absolute;
top: 0.05em;
left: 0.17em;
background-color: transparent;
border-right: solid var(--bg) 0.08em;
border-bottom: solid var(--bg) 0.08em;
font-size: 1.8em;
transform: rotate(45deg);
}
input[type="radio"]:checked::after {

content: " ";
width: 0.25em;
height: 0.25em;
border-radius: 100%;
position: absolute;
top: 0.125em;
background-color: var(--bg);
left: 0.125em;
font-size: 32px;
}

@media only screen and (max-width: 720px) {
textarea,
select,
input {
width: 100%;
}
}

input[type="color"] {
height: 2.5rem;
padding: 0.2rem;
}

input[type="file"] {
border: 0;
}

hr {
border: none;
height: 1px;
background: var(--border);
margin: 1rem auto;
}
mark {
padding: 2px 5px;
border-radius: var(--standard-border-radius);
background-color: var(--marked);
color: black;
}
img,
video {
max-width: 100%;
height: auto;
border-radius: var(--standard-border-radius);
}
figure {
margin: 0;
display: block;
overflow-x: auto;
}
figcaption {
text-align: center;
font-size: 0.9rem;
color: var(--text-light);
margin-bottom: 1rem;
}
blockquote {
margin-inline-start: 2rem;
margin-inline-end: 0;
margin-block: 2rem;
padding: 0.4rem 0.8rem;
border-inline-start: 0.35rem solid var(--accent);
color: var(--text-light);
font-style: italic;
}
cite {
font-size: 0.9rem;
color: var(--text-light);
font-style: normal;
}
dt {
color: var(--text-light);
}

code,
pre,
pre span,
kbd,
samp {
font-family: var(--mono-font);
color: var(--code);
}
kbd {
color: var(--preformatted);
border: 1px solid var(--preformatted);
border-bottom: 3px solid var(--preformatted);
border-radius: var(--standard-border-radius);
padding: 0.1rem 0.4rem;
}
pre {
padding: 1rem 1.4rem;
max-width: 100%;
overflow: auto;
color: var(--preformatted);
}

pre code {
color: var(--preformatted);
background: none;
margin: 0;
padding: 0;
}



progress {
width: 100%;
}
progress:indeterminate {
background-color: var(--accent-bg);
}
progress::-webkit-progress-bar {
border-radius: var(--standard-border-radius);
background-color: var(--accent-bg);
}
progress::-webkit-progress-value {
border-radius: var(--standard-border-radius);
background-color: var(--accent);
}
progress::-moz-progress-bar {
border-radius: var(--standard-border-radius);
background-color: var(--accent);
transition-property: width;
transition-duration: 0.3s;
}
progress:indeterminate::-moz-progress-bar {
background-color: var(--accent-bg);
}
dialog {
max-width: 40rem;
margin: auto;
}
dialog::backdrop {
background-color: var(--bg);
opacity: 0.8;
}
@media only screen and (max-width: 720px) {
dialog {
max-width: 100%;
margin: auto 1em;
}
}

.notice {
background: var(--accent-bg);
border: 2px solid var(--border);
border-radius: 5px;
padding: 1.5rem;
margin: 2rem 0;
}

strong{
color:#d81b60;
}
em {
color:#e0467e; 
}
hr
{
border: 1px;
clear: both;
display: block;
width: 100%;
height: 1px;

background-color:#686868
}
</style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">Your Digest for Tuesday, Jan 23, 2024 10:59 AM</h1>
</header>
<hr />
<h1 id="meningioma">Meningioma</h1>
<p>#2017GM-OCT/Q18</p>
<ul>
<li><strong>Benign</strong>, <strong>slow growing tumours</strong> arising from the <strong>arachnoid</strong>.</li>
<li>Can cause local bone erosions.</li>
<li>Psammoma bodies (Form of dystrophic calcification) are present on histology.</li>
<li>Rare below the tentorium.</li>
<li>Common sites: parasagittal, pituitary fossa etc.</li>
<li></li>
</ul>
<hr />
<ul>
<li>Arise from ECL cells in the <strong>GI system and bronchopulmonary</strong> systems. ^543118</li>
<li>Also called <strong>APUDOMAs</strong></li>
<li>Majority occurs in the GI system, particularly in the small intestine.</li>
</ul>
<blockquote>
<p>The most common biologically active substance secreted from carcinoid tumors is 5-HT (<strong>serotonin</strong>), a vasoactive peptide whose biosynthesis is accomplished nearly exclusively by the <strong>enterochromaffin</strong> cells. Synthesized from the amino acid <strong>tryptophan</strong>, the release of <strong>5-HT</strong> into the systemic circulation can cause the classic symptoms of the carcinoid syndrome, which include <strong>diarrhea, episodic flushing, bronchoconstriction, and eventual right-sided valvular heart disease</strong> (and probably oedema from right heart failure?)<br />
old test was urinary <strong>5-hydroxyindoleacetic acid</strong>.<br />
Can also use plasma level of 5-hydroxyindoleacetic acid.</p>
</blockquote>
<hr />
<p>#2017GM-OCT/Q19<br />
- <strong>persistent generalized lymphadenopathy</strong> can be a presenting feature.</p>
<hr />
<p><em>Unilateral</em>, <em>severe</em> headaches with associated <em>ipsilateral cranial autonomic symptoms</em> usually in the <strong>ophthalmic division</strong> of trigeminal nerve.</p>
<p>SUNCT:</p>
<ul>
<li>Short lasting neuralgiform headache with conjunctival injection and tearing<br />
SUNA:</li>
<li></li>
</ul>
<table>
<thead>
<tr class="header">
<th>-</th>
<th><strong>Cluster</strong></th>
<th><strong>Paroxysmal hemicrania</strong></th>
<th>SUNCT / SUNA</th>
<th>Hemicrania continua</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Site</td>
<td>Orbital or temporal</td>
<td>Orbital or temporal</td>
<td>Orbital or temporal</td>
<td>Orbital, frontal, and/or temporal</td>
</tr>
<tr class="even">
<td>Typical attack frequency</td>
<td>1 every other day to 8 daily</td>
<td>5 to 40 daily</td>
<td>1 to 200 daily</td>
<td>Continuous (with exacerbations)</td>
</tr>
<tr class="odd">
<td>Duration of attack</td>
<td>15 to <strong>180 minutes</strong></td>
<td>2 to <strong>30 minutes</strong></td>
<td><strong>1 second to 10 minutes</strong></td>
<td>Months to years (untreated)</td>
</tr>
<tr class="even">
<td></td>
<td>Males 20-40 yo</td>
<td>Women &gt; men</td>
<td>-</td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td><strong>Clusters last months</strong></td>
<td><strong>Does not occur in clusters</strong></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td><em>Oxygen</em><br>Sub cut. <em>sumatriptan</em> for rapid relief<br><em>Verapamil</em> / <em>steroids</em> to terminate a cluster</td>
<td><strong>Indomethacin</strong></td>
<td>very rare</td>
<td>very rare</td>
</tr>
</tbody>
</table>
<h3 id="trigeminal-neuralgia">Trigeminal neuralgia</h3>
<ul>
<li>&quot;<em>neur</em>algia&quot; not &quot;<em>ceph</em>algia&quot;</li>
<li>Classified as &quot;facial pain&quot;.</li>
<li><strong>Electric, shock like pain</strong> lasting <strong>seconds</strong></li>
<li>Occurs in elderly, hypertension is the main risk factor.</li>
<li>Aberrant vascular loop causes compression of trigenimal nerve.</li>
<li>?no autonomic trigeminal symptoms</li>
<li>Spontaneous remission occurs lasting months but disease <strong>invariably recurs</strong></li>
<li><strong>Treatment</strong>: Carbamazepine, surgical treatment is second line but more effective. (RF ablation)</li>
<li></li>
</ul>
<hr />
<p>#2017GM-OCT/Q17</p>
<ul>
<li>Extradrenal tumours (paragangliomas) produce mainly <strong>noradrenaline</strong>. Others produce both. [[2020-BasicSciences-July#Autonomic nervous system and organization]]</li>
</ul>
<ul>
<li>Unlike the healthy adrenal medulla, pheochromocytomas are not innervated, and <em>catecholamine release is not precipitated by neural stimulation.</em> The trigger for catecholamine release is unclear, but multiple mechanisms have been postulated, including direct pressure, medications, and <strong>changes in tumor blood flow</strong>.</li>
<li>Norepinephrine signals through <strong>α1, α2, and β1</strong> receptors, while <strong>epinephrine will primarily stimulate only β1 and β2</strong> receptors.
<ul>
<li>Symptoms include the obvious ones as well as flushing / pallor, constipation or diarrhoea and Raynaud&#39;s phenomenon, polyuria and nocturia, glycosuria, orthostatic <em>hypotension</em> (possibly due to fluctuation of vascular tone).</li>
</ul></li>
</ul>
<ul>
<li><strong>Associations</strong>: <em>neurofibromatosis</em>, [[2022-November#Multiple Endocrine neoplasia syndromes|MEN2]], [[passMedicine Summaries#Von hippel-lindau disease|VHL]]and
<ul>
<li>Alpha blockade (<em>phenoxybenzamine</em>) must precede beta blockade (propranolol)</li>
<li>Chronic alpha stimulation -&gt; Hypertension -&gt; <em>compensatory salt and water loss</em> -&gt; hypotension during alpha blockade.
<ul>
<li>Pt. <strong>needs salt rich diet with prehydration</strong>.</li>
</ul></li>
<li>Alpha blockade <strong>must precede</strong> beta blockade. (otherwise, risk of <strong>worsened hypertension</strong>)</li>
</ul></li>
</ul>
</body>
</html>
